MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    Treatment of hemichorea-hemiballism with valbenazine

    J. Leegwater-Kim (BURLINGTON, MA, USA)

    Objective: To describe a video-case report of hemichorea-hemiballism improved by valbenazine therapy Background: Hemichorea-hemiballism (HCHB) is an uncommon movement disorder with numerous etiologies including structural…
  • MDS Virtual Congress 2020

    Real-World Healthcare Resource Utilization in Patients with Parkinson’s Disease and Motor Fluctuations

    M. Serbin, S. Odak, C. Macahilig, N. Joshi, A. Shah, X. Ng, K. Olson, G. Liang, O. Klepitskaya, C. Yonan (San Diego, CA, USA)

    Objective: To evaluate healthcare resource utilization (HCRU) patterns in patients with Parkinson’s disease (PD) and motor fluctuations (MF) with carbidopa/levodopa (CD/LD) and other adjunctive PD…
  • MDS Virtual Congress 2020

    Trends and Racial Disparities of Palliative Care Use among Hospitalized Patients with Parkinson’s Disease

    S. Jimsheleishvili, D. Di Luca, M. Feldman, J. Margolesky, D. Shpiner, C. Singer, C. Luca (Miami, FL, USA)

    Objective: To analyze the rate of palliative care consultations among hospitalized patients with Parkinson’s Disease (PD) using the National Inpatient Sample data from 2007 to…
  • MDS Virtual Congress 2020

    Discrimination of alpha-synuclein strains and sub-strains in Synucleinopathies

    M. Shahnawaz, A. Mukherjee, S. Pritzkow, N. Dinamarca, F. Wang, P. Rabadia, C. Soto (Houston, TX, USA)

    Objective: To differentiate and characterize alpha-synuclein strains and sub-strains associated with synucleinopathies. Background: Synucleinopathies are a diverse group of neurodegenerative diseases characterized by misfolding aggregation…
  • MDS Virtual Congress 2020

    Parkinson’s disease patients at Hoehn and Yahr stage 1 show deficits in reactive but not proactive inhibitory control

    V. Di Caprio, N. Modugno, C. Mancini, E. Olivola, G. Mirabella (Pozzilli, Italy)

    Objective: We wanted to assess whether i) Parkinson’s disease (PD) patients at Hoehn and Yahr (HY) stage 1 show a global or a selective impairment…
  • MDS Virtual Congress 2020

    Baseline Predictors of Constipation and Probable Rapid Eye Movement Sleep Behavior Disorder (pRBD) for Cognitive Impairment After 5 Years of Parkinson’s Disease (PD) Diagnosis in the Parkinson’s Progression Markers Initiative Cohort (PPMI)

    W.L Kong, Y. Huang, E. Qian, M. Morris (Sydney, Australia)

    Objective: Cognitive impairment is linked to morbidity and mortality in patients with PD, this study aims to investigate whether the presence of constipation and RBD…
  • MDS Virtual Congress 2020

    What can tell us Non-Motor Symptoms about Cognition and Gait in the Early Stage of PD Patients

    B. Munoz Ospina, V. Quintana-Peña, D. Rincón, J. Valderrama, Y. Castaño-Pino, J. Orozco Velez, A. Navarro (Cali, Colombia)

    Objective: To describe the motor, cognitive and non-motor profiles in the early stage of PD using eMotion Kinect system, Moca Test and PD-CRS. Background: The…
  • MDS Virtual Congress 2020

    Does age at onset of Parkinson’s disease affect the development of dementia?

    P. Soliveri, F. Del Sorbo, A. Zecchinelli, G. Sacilotto, N. Meucci, M. Zini, C. Mariani, S. Tesei, G. Pezzoli (Milan, Italy)

    Objective: To investigate whether progression to dementia in senile Parkinson’s disease, SPD, (disease onset after 70 years) differs from that in old Parkinson’s disease, OPD,…
  • MDS Virtual Congress 2020

    Cognitive profiling of patients with neurodegenerative disorders

    I. Zhukova, E. Kolupaeva, N. Zhukova, O. Izhboldina, M. Nikitina, A. Latipova, S. Shtaymets, I. Mironova, Z.h Kislukhina, L. Tkachenko, A. Agasheva, D. Novotnyy (Tomsk, Russian Federation)

    Objective: To characterise the cognitive decline of patients with neurodegenerative disorders: Parkinson’s disease (PD), Alzheimer's disease (AD) and essential tremor (ET) and to compare their neuropsychological…
  • MDS Virtual Congress 2020

    Optic atrophy and parkinsonism in a family associated with OPA1 mutation

    Y.T Hsu, S.P Liu, W.D Lin, C.H Tsai (Taichung, Taiwan)

    Objective: To report a Taiwanese family with a heterozygous missense mutation of OPA1 gene (NM_130836, p.Ser582Arg) presenting with optic atrophy and parkinsonism and establish an…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 149
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley